---
title: "600056.SH (600056.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600056.SH/news.md"
symbol: "600056.SH"
name: "600056.SH"
parent: "https://longbridge.com/en/quote/600056.SH.md"
datetime: "2026-05-20T10:04:24.941Z"
locales:
  - [en](https://longbridge.com/en/quote/600056.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600056.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600056.SH/news.md)
---

# 600056.SH (600056.SH) — Related News

### [China Meheco: Net profit in the first quarter was 182 million yuan, a year-on-year increase of 5.58%](https://longbridge.com/en/news/284376349.md)
*2026-04-28T11:37:00.000Z*
> China Meheco disclosed its Q1 report on April 28, showing that the company achieved operating revenue of 8.189 billion y

### [China Meheco: Subsidiary obtains drug registration certificate for injectable Nicorandil](https://longbridge.com/en/news/283323151.md)
*2026-04-20T09:07:06.000Z*
> China Meheco's wholly-owned subsidiary Tianfang Pharmaceutical has obtained the drug registration certificate for inject

### [Ministry of Commerce: Nearly 1,000 retail pharmacies have been upgraded to "Health Stations"](https://longbridge.com/en/news/280968714.md)
*2026-03-30T06:57:37.000Z*
> The Ministry of Commerce announced that nearly 1,000 retail pharmacies have been upgraded to "Health Stations," providin

### [Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash Flow](https://longbridge.com/en/news/279810360.md)
*2026-03-19T14:11:02.000Z*
> Sinopharm Group Co. has reported its 2025 financial results for its subsidiary, China National Medicines Corporation. Re

### ["Beijing Special Report" The scale of Beijing's pharmaceutical and health industry exceeds one trillion, and this year will introduce 32 new measures to promote pharmaceutical innovation](https://longbridge.com/en/news/279544132.md)
*2026-03-18T06:27:00.000Z*
> The scale of the pharmaceutical and health industry in Beijing has reached 1.13 trillion yuan, and it is expected to con

### [China Meheco: Injectable Isavuconazole has obtained a drug registration certificate](https://longbridge.com/en/news/279393543.md)
*2026-03-17T08:28:10.000Z*
> China Meheco announced that its wholly-owned subsidiary Hainan General Sanyou Pharmaceutical has obtained the "Drug Regi

### [China Meheco: Subsidiary Tianfang Pharmaceutical has received the approval notice for the supplementary application of Minoxidil topical solution](https://longbridge.com/en/news/277907741.md)
*2026-03-05T08:56:54.000Z*
> China Meheco announced that its wholly-owned subsidiary Tianfang Pharmaceutical has received two "Drug Supplement Applic

### [China Meheco: Subsidiary obtains Drug Registration Certificate for injectable phosphoethanolamine](https://longbridge.com/en/news/276852614.md)
*2026-02-25T08:03:00.000Z*
> China Meheco's wholly-owned subsidiary, Kangli Pharmaceutical, has obtained the Drug Registration Certificate for inject

### [China Meheco: Subsidiary obtains drug registration certificate](https://longbridge.com/en/news/275304804.md)
*2026-02-09T11:00:08.000Z*
> China Meheco's wholly-owned subsidiary Tianfang Pharmaceutical has obtained the Drug Registration Certificate approved b